Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Study Protocol and Statistical Analysis Plan document version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T23:21:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No user-facing content appears to be changed.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:24.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown. The previously displayed notices about government funding lapse (v3.4.1) have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T04:43:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows an administrative notice about a lapse in government funding and an updated revision tag (v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T03:28:40.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The update adds a glossary display option and updates several page labels and revision text, for example 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels like 'No FEAR Act Data' are removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:35:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this minor version change does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:15:35.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.